| Marc Philip Gruner, DO | |
|
8401 Greensboro Dr Ste 120, Mc Lean, VA 22102-5101 | |
| (571) 899-3590 | |
| (571) 378-1302 |
| Full Name | Marc Philip Gruner |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 9 Years |
| Location | 8401 Greensboro Dr Ste 120, Mc Lean, Virginia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760877492 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 65424 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bethesda Chevy Chase Orthopaedic Associates, Llc | 4789631011 | 122 |
News Archive
Delivering genetic test results to patients at risk for cancer-causing genetic mutations over the phone helps to ease cost and transportation burdens and, compared to receiving results in person, does not cause patients additional stress, according to a new study from the Abramson Cancer Center of the University of Pennsylvania which will be presented at the American Society of Clinical Oncology Annual Meeting.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.
A Japanese research team has developed a cyclic peptide (a chain of amino acids bonded circularly) that enhances blood-brain barrier penetration.
Celgene Corporation today announced it has completed its acquisition of Avila Therapeutics. Celgene acquired Avila Therapeutics for $350 million in cash, plus up to $575 million contingent upon certain milestones related to AVL-292 and candidates from Avila's discovery program.
Eat fish, but avoid fish with the most pollutants. This is the conclusion drawn by a group of researchers at Umeå University in Sweden after having weighed the risks of mercury content against the advantages of healthful fatty acids. The work was done as part of an international collaborative effort.
› Verified 1 days ago
| Entity Name | Bethesda Chevy Chase Orthopaedic Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477583599 PECOS PAC ID: 4789631011 Enrollment ID: O20050407000997 |
News Archive
Delivering genetic test results to patients at risk for cancer-causing genetic mutations over the phone helps to ease cost and transportation burdens and, compared to receiving results in person, does not cause patients additional stress, according to a new study from the Abramson Cancer Center of the University of Pennsylvania which will be presented at the American Society of Clinical Oncology Annual Meeting.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.
A Japanese research team has developed a cyclic peptide (a chain of amino acids bonded circularly) that enhances blood-brain barrier penetration.
Celgene Corporation today announced it has completed its acquisition of Avila Therapeutics. Celgene acquired Avila Therapeutics for $350 million in cash, plus up to $575 million contingent upon certain milestones related to AVL-292 and candidates from Avila's discovery program.
Eat fish, but avoid fish with the most pollutants. This is the conclusion drawn by a group of researchers at Umeå University in Sweden after having weighed the risks of mercury content against the advantages of healthful fatty acids. The work was done as part of an international collaborative effort.
› Verified 1 days ago
| Entity Name | Mark D. Klaiman, M.d., L.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225218506 PECOS PAC ID: 2365653391 Enrollment ID: O20110120000931 |
News Archive
Delivering genetic test results to patients at risk for cancer-causing genetic mutations over the phone helps to ease cost and transportation burdens and, compared to receiving results in person, does not cause patients additional stress, according to a new study from the Abramson Cancer Center of the University of Pennsylvania which will be presented at the American Society of Clinical Oncology Annual Meeting.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.
A Japanese research team has developed a cyclic peptide (a chain of amino acids bonded circularly) that enhances blood-brain barrier penetration.
Celgene Corporation today announced it has completed its acquisition of Avila Therapeutics. Celgene acquired Avila Therapeutics for $350 million in cash, plus up to $575 million contingent upon certain milestones related to AVL-292 and candidates from Avila's discovery program.
Eat fish, but avoid fish with the most pollutants. This is the conclusion drawn by a group of researchers at Umeå University in Sweden after having weighed the risks of mercury content against the advantages of healthful fatty acids. The work was done as part of an international collaborative effort.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc Philip Gruner, DO 10215 Fernwood Rd Ste 506, Bethesda, MD 20817-1184 Ph: (301) 350-1010 | Marc Philip Gruner, DO 8401 Greensboro Dr Ste 120, Mc Lean, VA 22102-5101 Ph: (571) 899-3590 |
News Archive
Delivering genetic test results to patients at risk for cancer-causing genetic mutations over the phone helps to ease cost and transportation burdens and, compared to receiving results in person, does not cause patients additional stress, according to a new study from the Abramson Cancer Center of the University of Pennsylvania which will be presented at the American Society of Clinical Oncology Annual Meeting.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.
A Japanese research team has developed a cyclic peptide (a chain of amino acids bonded circularly) that enhances blood-brain barrier penetration.
Celgene Corporation today announced it has completed its acquisition of Avila Therapeutics. Celgene acquired Avila Therapeutics for $350 million in cash, plus up to $575 million contingent upon certain milestones related to AVL-292 and candidates from Avila's discovery program.
Eat fish, but avoid fish with the most pollutants. This is the conclusion drawn by a group of researchers at Umeå University in Sweden after having weighed the risks of mercury content against the advantages of healthful fatty acids. The work was done as part of an international collaborative effort.
› Verified 1 days ago
David C Wang, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 6829 Elm St, Suite 300, Mc Lean, VA 22101 Phone: 703-532-4892 Fax: 703-237-3105 | |
Jennifer Coulter, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8008 Westpark Dr, Mc Lean, VA 22102 Phone: 703-287-6400 | |
Dr. Danielle Sunshine Cherrick, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1760 Old Meadow Rd, Ste 500, Mc Lean, VA 22102 Phone: 703-810-5217 Fax: 703-810-5423 | |
Christina Victor, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1420 Spring Hill Rd, Mc Lean, VA 22102 Phone: 571-765-1730 | |
Mayo F Friedlis, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1750 Tysons Blvd Ste 120, Mc Lean, VA 22102 Phone: 703-914-8000 Fax: 703-642-1876 | |
Dr. Spencer T Tseng, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8008 Westpark Dr, Mc Lean, VA 22102 Phone: 703-287-4675 Fax: 703-922-1111 |